Skip to main content

Books in Rheumatology

71-80 of 93 results in All results

Rheumatic Rarities, An Issue of Rheumatic Disease Clinics

  • 1st Edition
  • Volume 39-2
  • April 25, 2013
  • Jonathan Kay
  • English
  • Hardback
    9 7 8 - 1 - 4 5 5 7 - 7 3 8 3 - 1
  • eBook
    9 7 8 - 1 - 4 5 5 7 - 7 3 8 4 - 8
Guest edited by Jonathan Kay, this issue of Rheumatic Disease Clinics will cover the latest research and evidence surrounding the diagnosis, treatment and management of rarely seen rheumatic diseases.

Update on Osteoarthritis, An Issue of Rheumatic Disease Clinics

  • 1st Edition
  • Volume 39-1
  • January 25, 2013
  • David J. Hunter
  • English
  • Hardback
    9 7 8 - 1 - 4 5 5 7 - 7 3 2 8 - 2
  • eBook
    9 7 8 - 1 - 4 5 5 7 - 7 3 5 5 - 8
Osteoarthritis is the leading cause of disability among older adults affecting upward of 1 in 8 adults. This issue will cover epidemiology, imaging, disease management and modification, and many more topics.

Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics

  • 1st Edition
  • Volume 38-4
  • November 9, 2012
  • John J Cush + 1 more
  • English
  • Hardback
    9 7 8 - 1 - 4 5 5 7 - 5 0 6 5 - 8
  • eBook
    9 7 8 - 1 - 4 5 5 7 - 5 0 5 9 - 7
Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today––drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.

Best Practice & Research. Reumatología clínica, vol. 25, n.º 1

  • 1st Edition
  • September 16, 2012
  • Philip Sambrook + 1 more
  • Spanish
  • eBook
    9 7 8 - 8 4 - 4 5 8 - 2 4 0 1 - 6
Esta serie ofrece una actualización continua de la práctica clínica actual, cubre todo el espectro de trastornos del aparato locomotor. Cada uno de los títulos sigue un enfoque orientado a la resolución de problemas, y se centra en las cuestiones clave a tratar. ¿Cómo se deben reconocer, investigar ,diagnosticar y tratar los trastornos  musculoesqueléticos relacionados con el trabajo? Es la conexión con el trabajo relevante?  Los artículos presentados en esta obra ofrecen respuestas basadas en la evidencia para estas y otras preguntas. El monográfico pone de manifiesto que los trastornos musculoesqueléticos relacionados con el trabajo son un grupo importante de las condiciones que suponen un importante desafío para el clínico. La información ofrecida proporciona una guía para ayudar al especialista en la toma racional de decisiones y en el desarrollo de planes de gestión adecuados para aquellos a los que su actividad profesional afecta a la aparición, la gravedad y la cronicidad de problemas musculoesqueléticos.

Spondyloarthropathies, An Issue of Rheumatic Disease Clinics

  • 1st Edition
  • Volume 38-3
  • August 28, 2012
  • Juergen Braun + 1 more
  • English
  • Hardback
    9 7 8 - 1 - 4 5 5 7 - 5 0 6 6 - 5
  • eBook
    9 7 8 - 1 - 4 5 5 7 - 5 0 6 0 - 3
Edited by Drs. Juergen Braun and Joachim Sieper, this issue of Rheumatic Disease Clinics comprehensively reviews the state of the art of spondyloarthritis (SpA) diagnosis, prognosis, pathogenesis and genetic insights, and treatment. The worldwide burden of SpA now exceeds that of rheumatoid arthritis. General topics covered include inflammatory back pain, pathophysiology, imaging techniques, and therapeutic strategies.

Early Arthritis, An Issue of Rheumatic Disease Clinics

  • 1st Edition
  • Volume 38-2
  • May 28, 2012
  • Karen Torralba + 2 more
  • English
  • Hardback
    9 7 8 - 1 - 4 5 5 7 - 3 9 3 2 - 5
  • eBook
    9 7 8 - 1 - 4 5 5 7 - 4 4 3 6 - 7
To ensure the best possible clinical outcomes for arthritis patients, it is essential that they be seen early and treated appropriately at the earliest opportunity. Early therapy has proven much more effective than that given late. This issue of Rheumatic Disease Clinics of North America brings the rheumatologist up to date on the latest treatments and interventions in evolving arthritis and established early arthritis. Topics covered include early rheumatoid arthritis, psoriatic arthritis, undifferentiated arthritis, oligoarthritis, osteoarthritis, and others. Imaging modalities are addressed as well as various contemporary treatments including biologics.

Vitamin D, An Issue of Rheumatic Disease Clinics

  • 1st Edition
  • Volume 38-1
  • February 28, 2012
  • Sol Epstein
  • English
  • Hardback
    9 7 8 - 1 - 4 5 5 7 - 3 9 3 1 - 8
  • eBook
    9 7 8 - 1 - 4 5 5 7 - 4 3 1 3 - 1
This issue features internationally renowned experts who have provided their expertise on a variety of topics related to the importance of vitamin D. It was not until feed back loops were identified between Vitamin D production and parathyroid hormone, phosphate that it earned its place as a true endocrine hormone. Current social and economic conditions have brought it back into the limelight with outbreaks of rickets and osteomalacia even in developed countries. However its complex regulation, together with the identification and characterization of the vitamin D receptor and its role in influencing multiple genetic pathways and function has heralded a new era highlighting its importance in health and disease. This includes its role in auto immune diseases such as multiple sclerosis, diabetes mellitus, cancer especially breast and prostate, skin, neurological and cognitive disorders and infectious diseases such as tuberculosis. We now know that adequate levels of vitamin D it is important in preventing falls and fracture. The need for supplementation and the amount recommended has also changed considerably from what we previously considered sufficient. The ongoing development of selective active analogs of vitamin D targeted to specific organs and function leads to the exciting possibility of improving outcomes of diseases associated with vitamin D regulation.

Pathologies musculosquelettiques douloureuses

  • 1st Edition
  • January 1, 2012
  • John Scott & Co + 3 more
  • French
  • eBook
    9 7 8 - 2 - 2 9 4 - 7 2 8 3 5 - 8
Le Dr Steven D. Waldman, spécialiste de la prise en charge de la douleur, et le Dr Robert Campbell, radiologue connu, ont conjugué leurs compétences pour rédiger cet ouvrage. Il offre les clés pour déterminer les examens d'imagerie indispensables pour l'évaluation clinique de 200 pathologies musculosquelettiques. Le livre est découpé en 6 parties : - techniques d'imagerie permettant le diagnostic de la douleur ; - rachis ; - épaule, coude et extrémités supérieures ; - bassin, hanche et extrémités inférieures ; - genou ; - cheville et pied. Synthétiques et faciles à consulter, les chapitres suivent un plan identique : définition, symptômes, épidémiologie, stratégie diagnostique, interprétation des examens d'imagerie, autres examens utiles, diagnostic différentiel, traitement. Ils sont étayés par de multiples clichés radiologiques (radiologie standard, échographie, IRM, scanner…).

Paraneoplastic and Cancer Treatment-Related Rheumatic Disorders, An Issue of Rheumatic Disease Clinics

  • 1st Edition
  • Volume 37-4
  • December 13, 2011
  • Kenneth J. Scalapino + 1 more
  • English
  • Hardback
    9 7 8 - 1 - 4 5 5 7 - 1 1 8 9 - 5
This issue of Rheumatic Disease Clinics of North America provides foundational and in-depth information about paraneoplastic and cancer treatment-related rheumatic disorders, in which every practicing rheumatologist should be well-versed. Topics covered include neoplasm risk in patients with rheumatic diseases; neoplasm risk of anti-rheumatic therapy; rheumatologic laboratory findings in malignancy; rheumatic manifestations of primary and metastatic bone tumors and paraneoplastic bone disease; neoplastic/paraneoplastic synovitis; neoplastic/paraneoplastic dermatitis, fasciitis, and panniculitis; neoplastic/paraneoplastic vasculitis, vasculopathy, and hypercoagulability; neoplastic/paraneoplastic myalgias and myositis; and less-common neoplastic/paraneoplastic syndromes.

Osteoporosis, An Issue of Rheumatic Disease Clinics

  • 1st Edition
  • Volume 37-3
  • August 28, 2011
  • Stuart L. Silverman
  • English
  • Hardback
    9 7 8 - 1 - 4 5 5 7 - 7 9 9 1 - 8
  • eBook
    9 7 8 - 1 - 4 5 5 7 - 0 9 5 3 - 3
This timely and evocative issue of Rheumatic Disease Clinics explores important current and controversial topics in the treatment of osteoporosis. And it answers some tough questions! Here are some examples. How long do I treat my patient? Is there a place for bone turnover markers? How much Vitamin D should I recommend? Controversies around calcium and Vitamin D are explored regarding the coronary risk and pancreatic issues. Emerging therapies are presented, including sclerostin and oral calcitonin. Long-term safety concerns of antiresporptive therapy (ONJ, atypical fracture, would healing) are explained. The utility and limitations of FRAX are covered, as well as Prolia and the RANKL pathway. An update on glucocorticoid induced OP is given. The reader is also brought up to date on men’s health issues and OP. This is an essential issue for any practicing rheumatologist to stay current in the field.